NCT05676190View on ClinicalTrials.gov

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

April 30, 2027

Conditions
Colorectal Cancer
Interventions
COMBINATION_PRODUCT

CIK combined with chemotherapy group

Combination of chemotherapy and autologous cytokine induced killer cells

COMBINATION_PRODUCT

CIK combined immunotherapy group

Combination of immunotherapy and autologous cytokine induced killer cells

COMBINATION_PRODUCT

CIK combined targeted therapy group

Combination of targeted therapy and autologous cytokine induced killer cells

COMBINATION_PRODUCT

CIK in combination with other therapies

CIK combined with any two or three of them (i.e. chemotherapy, immunotherapy and targeted therapy)

Trial Locations (1)

400038

RECRUITING

Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing

All Listed Sponsors
lead

ShiCang Yu

OTHER